Shein was once valued at close to $100 billion. By the time it reached the Hong Kong public market, that valuation had fallen dramatically.
Shein was once valued at close to $100 billion. By the time it reached the Hong Kong public market, that valuation had fallen dramatically.
Online fashion retailer Shein has received approval from China’s securities regulator to proceed with plans for a potential initial public offering in Hong Kong.
US semiconductor stocks looked set for a weaker start on Wall Street on Friday as investor enthusiasm around artificial intelligence continued to cool following a series of disappointing sector performances.
Shell reported stronger earnings after volatility in crude markets boosted performance in its oil trading operations during the latest quarter.
A significant legal dispute has emerged at London-based financial software firm FNZ, with hundreds of employee shareholders initiating a £3.5 billion class-action lawsuit against the company and 17 of its
The forex market can be full of opportunities but it is often volatile. With this volatility, it can be desperately hard to stay within a structure and be consistent. This
In a quietly staged stall in Central Park, selling original signed canvases for $60 each, with a totally ordinary-looking vendor. Thousands of people walked past, assuming it was tourist junk.
GENinCode plc (AIM: GENI) has conditionally raised £3.9m in gross proceeds through the issue of 388,145,000 new ordinary shares at 1p each, representing a 47.4pc discount to the closing middle
The Dow Jones Industrial Average pushed to another fresh record, lifted by strong gains in Amazon.
GENinCode Plc has entered into a commercial agreement with Sohin Genetics in Mexico to distribute its CARDIO inCode-Score® Polygenic Risk Score test, which is designed to help predict and prevent
GENinCode Plc (AIM: GENI) shares climbed 33% after the company announced a major collaboration with Thermo Fisher Scientific to commercialise its CARDIO inCode-Score® Polygenic Risk Score test for predicting and
GENinCode PLC (AIM: GENI) jumped 32% to 2.84p in early trading after securing approval from the New York State Department of Health (NYSDOH) for its CARDIO inCode-Score test, which assesses